Ceftazidime-Avibactam Plus Aztreonam for the Treatment of Blood Stream Infection Caused by <i>Klebsiella pneumoniae</i> Resistant to All Beta-Lactame/Beta-Lactamase Inhibitor Combinations.

Antibiotics (Basel) · 2025 · PMC12383220 · PMID 40868000

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The SOFA score on day 7 for the control group showed a trend towards being lower, but it was not statistically different between the groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Ceftazidime-Avibactam Plus Aztreonam for the Treatment of Blood Stream Infection Caused by &lt;i&gt;Klebsiella pneumoniae&lt;/i&gt; Resistant to All Beta-Lactame/Beta-Lactamase Inhibitor Combinations.

The sentences

Ceftazidime-Avibactam Plus Aztreonam for the Treatment of Blood Stream Infection Caused by <i>Klebsiella pneumoniae</i> Resistant to All Beta-Lactame/Beta-Lactamase Inhibitor Combinations.